Urinary PGE-MUM as a Marker for Ulcerative Colitis Activity | MicrobiomeTrials← Back to trialsNCT07637045
Urinary PGE-MUM as a Marker for Ulcerative Colitis Activity
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-08-01Est. Completion: 2027-01-31
Enrollment target: 114 participants Locations- Al-Rajhi University Hospital, Asyut, Egypt
Other microbiome trials you might be interested in
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Colitis
This Phase 2b randomized, double-blind, placebo-controlled, multicenter trial will evaluate the efficacy and safety of a…
Izmir, Turkey (Türkiye)Est. completion May 30, 2027